Bumper Offer - Urjas oil Just @ Rs. 1
Lamitor OD 100 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Seizures. Secondary and off-label uses of Lamitor OD 100 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Lamitor OD 100 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Lamitor OD 100 Tablet can also lead to other problems, which have been listed below. These side effects of Lamitor OD 100 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Lamitor OD 100 Tablet's effect during pregnancy is Moderate and Moderate while nursing. In addition, Lamitor OD 100 Tablet's effects on the liver, heart and kidney are discussed below in the Lamitor OD 100 Tablet related warnings section.
Lamitor OD 100 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Depression are examples of such conditions. Other conditions have been mentioned below in the Lamitor OD 100 Tablet contraindications section.
Besides this, Lamitor OD 100 Tablet may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Lamitor OD 100 Tablet is not safe while driving, and is not addiction.
Lamitor OD 100 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Lamitor OD 100 Tablet safe for pregnant women?
Lamitor may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Lamitor again without your doctor's advice.
Is the use of Lamitor OD 100 Tablet safe during breastfeeding?
Lamitor can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Lamitor OD 100 Tablet on the Kidneys?
Lamitor rarely affects the kidneys.
What is the effect of Lamitor OD 100 Tablet on the Liver?
Lamitor may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Lamitor OD 100 Tablet on the Heart?
Using Lamitor does not have any harmful effects on the heart.
Lamitor OD 100 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lamitor OD 100 Tablet unless your doctor advises you to do so -
Is this Lamitor OD 100 Tablet habit forming or addictive?
No, there is no any evidence that Lamitor OD 100 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Lamitor OD 100 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but consume Lamitor OD 100 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Lamitor OD 100 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Lamitor OD 100 Tablet
It is safe to take Lamitor OD 100 Tablet with food.
Interaction between Alcohol and Lamitor OD 100 Tablet
Taking Lamitor OD 100 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)
